Ravi P. Cholia

Research Instructor

University of Arkansas for Medical Sciences

faculty

7 h-index 10 pubs 323 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Ravi P. Cholia's research focuses on the molecular mechanisms underlying disease, particularly in the context of cancer and neurological conditions. His work investigates the role of specific enzymes and metabolic pathways in disease progression and potential therapeutic interventions. One area of his research examines the cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme, exploring how this enzyme influences the development of brain tumors. Additionally, Cholia has investigated the neuroprotective effects of nicotinamide riboside, a form of vitamin B3, demonstrating its ability to alleviate cisplatin-induced peripheral neuropathy through the activation of the SIRT2 enzyme. His scholarship metrics include an h-index of 7, with 10 total publications and 323 citations. He has collaborated with researchers such as Ratan Sadhukhan and Mousumi Patra at the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 7
  • Publications: 10
  • Citations: 323

Selected Publications

  • Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation (2022) DOI
  • Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation (2022) DOI
  • A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme (2021) DOI

Grants & Funding

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics